KPIs & Operating Metrics(New)
Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Shares OutstandingShares Outstanding (Weighted Average)
Others
Ratios

AbCellera Biologics (ABCL) Other Non Operating Income: 2019-2024

Historic Other Non Operating Income for AbCellera Biologics (ABCL) over the last 6 years, with Dec 2024 value amounting to $62.3 million.

  • AbCellera Biologics' Other Non Operating Income rose 101.55% to $3.4 million in Q4 2023 from the same period last year, while for Dec 2023 it was $14.4 million, marking a year-over-year increase of 36.19%. This contributed to the annual value of $62.3 million for FY2024, which is 339.97% up from last year.
  • AbCellera Biologics' Other Non Operating Income amounted to $62.3 million in FY2024, which was up 339.97% from $14.2 million recorded in FY2023.
  • In the past 5 years, AbCellera Biologics' Other Non Operating Income ranged from a high of $62.3 million in FY2024 and a low of $8.3 million during FY2020.
  • Its 3-year average for Other Non Operating Income is $29.0 million, with a median of $14.2 million in 2023.
  • As far as peak fluctuations go, AbCellera Biologics' Other Non Operating Income spiked by 369.00% in 2020, and later plummeted by 39.64% in 2022.
  • Over the past 5 years, AbCellera Biologics' Other Non Operating Income (Yearly) stood at $8.3 million in 2020, then soared by 110.17% to $17.5 million in 2021, then tumbled by 39.64% to $10.6 million in 2022, then skyrocketed by 34.12% to $14.2 million in 2023, then surged by 339.97% to $62.3 million in 2024.